JPS5665819A - Composition for mefenamic acid pharmaceutical - Google Patents
Composition for mefenamic acid pharmaceuticalInfo
- Publication number
- JPS5665819A JPS5665819A JP14083179A JP14083179A JPS5665819A JP S5665819 A JPS5665819 A JP S5665819A JP 14083179 A JP14083179 A JP 14083179A JP 14083179 A JP14083179 A JP 14083179A JP S5665819 A JPS5665819 A JP S5665819A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- acid
- mefenamic acid
- mefenamic
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
PURPOSE: The titled composition useful as an anti-inflammatory and analgesic agent, capable of accelerating the absorption through a digestive tract and suppressing the side effect, and comprising mefenamic acid, specific amounts of sorbitan fatty acid ester of polyoxyethylene and sucrose ester of a fatty acid.
CONSTITUTION: Mefenamic acid (fine powder of particle size ≤74μ) is incorporated with sorbitan fatty acid ester of polyoxyethylene, e.g. lauric or oleic acid having an HLB of 8W15, and sucrose ester of a fatty acid, e.g. palmitic, stearic or lauric acid having an HLB of 5W14, to give a composition. The mixing weight ratio of the mefenamic acid to the esters of the fatty acid is preferably 1:0.4W1:0.7. The two types of fatty acid esters will not reduce the drug action even in the case of the mefenamic acid in an amount 1/2 the conventional one. Thus, the dose can be reduced to suppress side effects, e.g. gastroenteric trouble.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14083179A JPS5665819A (en) | 1979-10-31 | 1979-10-31 | Composition for mefenamic acid pharmaceutical |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14083179A JPS5665819A (en) | 1979-10-31 | 1979-10-31 | Composition for mefenamic acid pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5665819A true JPS5665819A (en) | 1981-06-03 |
Family
ID=15277726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14083179A Pending JPS5665819A (en) | 1979-10-31 | 1979-10-31 | Composition for mefenamic acid pharmaceutical |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5665819A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60185714A (en) * | 1983-11-17 | 1985-09-21 | ヘルムツト オペル | Surface analgesic and inflammatory |
JPH023609A (en) * | 1988-06-21 | 1990-01-09 | Fujimoto Seiyaku Kk | Long-acting drug preparation containing nicardipine hydrochloride as active component |
JP2013501062A (en) * | 2009-08-03 | 2013-01-10 | エミスフィアー テクノロジーズ インコーポレイテッド | Rapid-acting naproxen composition with reduced gastrointestinal effects |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53133624A (en) * | 1977-04-25 | 1978-11-21 | Dai Ichi Seiyaku Co Ltd | Highly soluble rifamplicin solid preparation |
-
1979
- 1979-10-31 JP JP14083179A patent/JPS5665819A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53133624A (en) * | 1977-04-25 | 1978-11-21 | Dai Ichi Seiyaku Co Ltd | Highly soluble rifamplicin solid preparation |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60185714A (en) * | 1983-11-17 | 1985-09-21 | ヘルムツト オペル | Surface analgesic and inflammatory |
JPH023609A (en) * | 1988-06-21 | 1990-01-09 | Fujimoto Seiyaku Kk | Long-acting drug preparation containing nicardipine hydrochloride as active component |
JP2013501062A (en) * | 2009-08-03 | 2013-01-10 | エミスフィアー テクノロジーズ インコーポレイテッド | Rapid-acting naproxen composition with reduced gastrointestinal effects |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9404762A (en) | COMPOSITIONS FOR INHALATION AND PROCESS FOR ITS PREPARATION. | |
JPS55153715A (en) | Prolonged granule of theophylline | |
IE43083L (en) | Sustained release formulations | |
JPS5659710A (en) | Preventive and remedy for psoriasis | |
JPS5665819A (en) | Composition for mefenamic acid pharmaceutical | |
DE3665668D1 (en) | Pharmaceutical granulate containing ambroxol or bromohexine | |
HUT75230A (en) | Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide | |
JPS5781409A (en) | External plaster | |
NZ183398A (en) | High solid content ultravidet curable compositions: mixture of poly and mono ethyenically unsaturated ester polyether compounds | |
JPS5350316A (en) | Drug composition for oral administration | |
JPS5770815A (en) | Absorption improver | |
JPS56164750A (en) | Antifoaming agent for food | |
JPS56145223A (en) | Drug composition | |
JPS5686114A (en) | Pharmaceutical composition for suppository | |
JPS5484020A (en) | Composition for coating medicine and method for coating the same | |
JPS56166108A (en) | Base for cosmetic and medicine | |
JPS567720A (en) | Antiphlogistic agent | |
JPS56131344A (en) | Preparation of foaming fat or oil for cake | |
JPS5616408A (en) | Composition for drug | |
JPS5793914A (en) | Stabilizing method of scopolia root extract in pharmaceutical | |
JPS5640606A (en) | Preparation of stable drug | |
JPS52130905A (en) | Medicinal composition | |
GB1147731A (en) | Improvements relating to the stabilization of chlormethiazole | |
JPS55133316A (en) | Antilipemic agent | |
JPS537846A (en) | Combustion apparatus |